Specification for Ovarian Tissue Cryopreservation and Transplantation

doi:10.12114/j.issn.1007-9572.2023.0237

Chinese General Practice ›› 2023, Vol. 26 ›› Issue (23): 2836-2841.DOI: 10.12114/j.issn.1007-9572.2023.0237

• Standard Specifications • Previous Articles Next Articles

Specification for Ovarian Tissue Cryopreservation and Transplantation

Received:2023-04-25 Published:2023-08-15 Online:2023-04-28

卵巢组织冻存移植技术规范团体标准

^1. 首都医科大学附属北京妇产医院/北京妇幼保健院内分泌科

基金资助:
北京市卫生健康委员会北京市研究型病房示范建设项目(BCRW202109); 北京市自然科学基金(7202047); 首都卫生发展科研专项资助(首发2020-2-2112); 北京市医院管理中心"登峰"计划专项经费资助(DFL20181401); 首都卫生发展科研专项资助(首发2016-2-2113); 北京市科学技术委员会首都临床特色应用研究项目(Z161100000516143); 北京市医院管理中心临床医学发展专项经费资助(XMLX201710)

Abstract

关键词: 卵巢, 卵巢组织冻存, 卵巢组织移植, 规范, 团体标准

Beijing Obstetrics and Gynecology Hospital，Capital Medical University,Committee of Fertility Protection and Preservation of China Association for the Promotion of Health Science and Technology. Specification for Ovarian Tissue Cryopreservation and Transplantation[J]. Chinese General Practice, 2023, 26(23): 2836-2841. DOI: 10.12114/j.issn.1007-9572.2023.0237.
首都医科大学附属北京妇产医院,中国人体健康科技促进会生育力保护与保存专业委员会. 卵巢组织冻存移植技术规范团体标准[J]. 中国全科医学, 2023, 26(23): 2836-2841. DOI: 10.12114/j.issn.1007-9572.2023.0237.

Figures/Tables 1

References 18

[1]	国际妇科内分泌学会中国妇科内分泌学分会及共识专家. 卵巢组织冻存与移植中国专家共识[J]. 中国临床医生杂志，2018，46(4):496-500. DOI：10.3969/j.issn.2095-8552.2018.04.042.
[2]	RUAN X Y. Chinese society of gynecological endocrinology affiliated to the international society of gynecological endocrinology guideline for ovarian tissue cryopreservation and transplantation[J]. Gynecol Endocrinol，2018，34(12):1005-1010. DOI：10.1080/09513590.2018.1488957.
[3]	RUAN X, DU J, LU D, et al. First live birth in China after cryopreserved ovarian tissue transplantation to prevent premature ovarian insufficiency[J]. Climacteric，2022，25(4):421-424. DOI：10.1080/13697137.2022.2064215.
[4]	RUAN X, DU J, LU D, et al. First pregnancy in China after ovarian tissue transplantation to prevent premature ovarian insufficiency[J]. Climacteric，2021，24(6):624-628. DOI：10.1080/13697137.2021.1956453.
[5]	RUAN X, DU J, KORELL M, et al. Case report of the first successful cryopreserved ovarian tissue retransplantation in China[J]. Climacteric，2018，21(6):613-616. DOI：10.1080/13697137.2018.1514005.
[6]	RUAN X, CHENG J, KORELL M, et al. Ovarian tissue cryopreservation and transplantation prevents iatrogenic premature ovarian insufficiency：first 10 cases in China[J]. Climacteric，2020，23(6):574-580. DOI：10.1080/13697137.2020.1767569.
[7]	Eshre Guideline Group on Female Fertility Preservation, Anderson R A, Amant F, et al. ESHRE guideline：female fertility preservation[J]. Hum Reprod Open，2020，2020(4):hoaa052. DOI：10.1093/hropen/hoaa052.
[8]	LAMBERTINI M, PECCATORI F A, DEMEESTERE I, et al. Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients：ESMO Clinical Practice Guidelines[J]. Ann Oncol，2020，31(12):1664-1678. DOI：10.1016/j.annonc.2020.09.006.
[9]	OKTAY K, HARVEY B E, LOREN A W. Fertility preservation in patients with cancer：ASCO clinical practice guideline update summary[J]. J Oncol Pract，2018，14(6):381-385. DOI：10.1200/JOP.18.00160.
[10]	YASMIN E, BALACHANDREN N, DAVIES M C, et al. Fertility preservation for medical reasons in girls and women：British fertility society policy and practice guideline[J]. Hum Fertil （Camb），2018，21(1):3-26. DOI：10.1080/14647273.2017.1422297.
[11]	Practice Committee of the American Society for Reproductive Medicine. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy：a committee opinion[J]. Fertil Steril，2019，112(6):1022-1033. DOI：10.1016/j.fertnstert.2019.09.013.
[12]	DIAZ A A, KUBO, HANDA N, et al. A systematic review of ovarian tissue transplantation outcomes by ovarian tissue processing size for cryopreservation[J]. Front Endocrinol （Lausanne），2022，13:918899. DOI：10.3389/fendo.2022.918899.
[13]	中国人体健康科技促进会生育力保护与保存专业委员会，国际妇科内分泌学会中国妇科内分泌学分会. 造血干细胞移植女童患者生育力保护中国专家共识[J]. 中国临床医生杂志，2022，50(9):1027-1032. DOI：10.3969/j.issn.2095-8552.2022.09.006.
[14]	RUAN X Y, Committee of Fertility Protection and Preservation of China Association for the Promotion of Health Science and Technology Chinese Society of Gynecological Endocrinology Affiliated to the International Society of Gynecological Endocrinology （CSGE-ISGE）. Expert consensus on fertility preservation in patients with breast cancer occurring during pregnancy[J]. Gynecol Endocrinol，2022，38(10):797-802. DOI：10.1080/09513590.2022.2122432.
[15]	DONNEZ J, DOLMANS M M. Fertility preservation in women[J]. N Engl J Med，2018，378(4):400-401. DOI：10.1056/NEJMc1715731.
[16]	MULDER R L, FONT-GONZALEZ A, VAN DULMEN-DEN B E, et al. Communication and ethical considerations for fertility preservation for patients with childhood，adolescent，and young adult cancer：recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group[J]. Lancet Oncol，2021，22(2):e68-80. DOI：10.1016/S1470-2045(20)30595-7.
[17]	SCHÜRING A N, FEHM T, BEHRINGER K, et al. Practical recommendations for fertility preservation in women by the FertiPROTEKT network. PartⅠ：indications for fertility preservation[J]. Arch Gynecol Obstet，2018，297(1):241-255. DOI：10.1007/s00404-017-4594-3.
[18]	VON WOLFF M, GERMEYER A, LIEBENTHRON J, et al. Practical recommendations for fertility preservation in women by the FertiPROTEKT network. PartⅡ：fertility preservation techniques[J]. Arch Gynecol Obstet，2018，297(1):257-267. DOI：10.1007/s00404-017-4595-2.

高风险	中风险	低风险
白血病	乳腺癌IV期，浸润性小叶型	乳腺癌Ⅰ~Ⅱ期，浸润性导管型
神经母细胞瘤	结肠癌	子宫颈鳞癌
Burkitt淋巴瘤	子宫颈腺癌	霍奇金淋巴瘤
	非霍奇金淋巴瘤	成骨癌
	尤文氏肉瘤	非生殖器官横纹肌肉瘤
		肾母细胞瘤

高风险	中风险	低风险
白血病	乳腺癌IV期，浸润性小叶型	乳腺癌Ⅰ~Ⅱ期，浸润性导管型
神经母细胞瘤	结肠癌	子宫颈鳞癌
Burkitt淋巴瘤	子宫颈腺癌	霍奇金淋巴瘤
	非霍奇金淋巴瘤	成骨癌
	尤文氏肉瘤	非生殖器官横纹肌肉瘤
		肾母细胞瘤

Specification for Ovarian Tissue Cryopreservation and Transplantation

卵巢组织冻存移植技术规范团体标准

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 1

References 18

Related Articles 0

Recommended Articles

Metrics

Comments